In vitro evaluation of the cytotoxicity and modulation of mechanisms associated with inflammation induced by perfluorooctanesulfonate and perfluorooctanoic acid in human colon myofibroblasts CCD-18Co

Toxicology in Vitro

Volumn 29, Issue 7, 2015, Pages 1683-1691

  Giménez Bastida, Juan Antonio ^a   Surma, Magdalena ^b   Zieliński, Henryk ^a  

^a INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

^b UNIVERSITY OF AGRICULTURE IN KRAKOW   (Poland)

Author keywords

Inflammation; Myofibroblasts CCD18 Co; Perfluorooctanesulfonate; Perfluorooctanoic acid; Polyfluoroalkyl and perfluoroalkyl acids

Indexed keywords

INTERLEUKIN 6; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; ALKANESULFONIC ACID; FLUOROCARBON; IL6 PROTEIN, HUMAN; OCTANOIC ACID DERIVATIVE; POLLUTANT;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; CYTOTOXICITY TEST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MYOFIBROBLAST; CELL LINE; CELL SURVIVAL; COLON; CYTOLOGY; DRUG EFFECTS; METABOLISM; POLLUTANT; TOXICITY;

ALKANESULFONIC ACIDS; CAPRYLATES; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; COLON; ENVIRONMENTAL POLLUTANTS; FLUOROCARBONS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MYOFIBROBLASTS;

EID: 84935130857     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.07.001     Document Type: Article

References (78)

1. Al-Sadi R., Ye D., Boivin M., Guo S., Hashimi M., Ereifej L., Ma T.Y. Interleukin-6 modulation of intestinal epithelial tight junction permeability is mediated by JNK pathway activation of claudin-2 gene. PLoS One 2014, 9:e85345.
2. Alsarra I.A., Brockmann W.G., Cunningham M.L., Badr M.Z. Hepatocellular proliferation in response to agonists of peroxisome proliferator-activated receptor alpha: a role for Kupffer cells?. J. Carcinog. 2006, 5:26-31.
3. Andersen M.E., Butenhoff J.L., Chang S.C., Farrar D.G., Kennedy G.L., Lau C., Olsen G.W., Seed J., Wallace K.B. Perfluoroalkyl acids and related chemistries-toxicokinetics and modes of action. Toxicol. Sci. 2008, 102:3-14.
4. Andoh A., Bamba S., Brittan M., Fujiyama Y., Wright N.A. Role of intestinal subepithelial myofibroblasts in inflammation and regenerative response in the gut. Pharmacol. Ther. 2007, 114:94-106.
5. Arigony A.L.V., Marques de Oliveira I., Machado M., Bordin D.L., Bergter L., Prá D., Henriques J.A.P. The influence of micronutrients in cell culture: a reflection on viability and genomic stability. BioMed. Res. Int. 2013, 2013:597282. 10.1155/2013/597282.
6. Benninghoff A.D., Bisson W.H., Koch D.C., Ehresman D.J., Kolluri S.K., Williams D.E. Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro. Toxicol. Sci. 2011, 120:42-58.
7. Berthiaume J., Wallace K.B. Perfluorooctanoate, perfluorooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis. Toxicol. Lett. 2002, 129:23-32.
8. Brieger A., Bienefeld N., Hasan R., Goerlich R., Haase H. Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytes. Toxicol. In Vitro 2011, 25:960-968.
9. Buck R.C., Franklin J., Berger U., Conder J.M., Cousins I.T., de Voogt P., Jensen A.A., Kannan K., Mabury S.A., van Leeuwen S.P.J. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integr. Environ. Assess. Manage. 2011, 7:513-541.
10. Buhrke T., Kibellus A., Lampen A. In vitro toxicological characterization of perfluorinated carboxylic acids with different carbon chain lengths. Toxicol. Lett. 2013, 218:97-104.
11. Butenhoff J.L., Chang S.C., Olsen G.W., Thomford P.J. Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in Sprague Dawley rats. Toxicology 2012, 293:1-15.
12. Calabrese E.J., Baldwin L.A., Holland C.D. Hormesis: a highly generalizable and reproducible phenomenon with important implications for risk assessment. Risk Anal. 1999, 19:261-281.
13. Catarzi S., Favilli F., Romagnoli C., Marcucci T., Picariello L., Tonelli F., Vincenzini M.T., Iantomasi T. Oxidative state and IL-6 production in intestinal myofibroblasts of Crohn's disease patients. Inflamm. Bowel Dis. 2011, 17:1674-1684.
14. Chang S.-C., Noker P.E., Gorman G.S., Gibson S.J., Hart J.A., Ehresman D.J., Butenhoff J.L. Comparative pharmacokinetics of perfluorooctanesulfonate (PFOS) in rats, mice and monkeys. Reprod. Toxicol. 2012, 33:428-440.
15. Chen Y.M., Guo L.H. Fluorescence study on site-specific binding of perfluoroalkyl acids to human serum albumin. Arch. Toxicol. 2009, 83:255-261.
16. 2-induced oxidative stress in Caco-2 cells. Food Chem. 2008, 106:1180-1187.
17. Coperchini F., Pignatti P., Lacerenza S., Negri S., Sideri R., Testoni C., de Martinis L., Cottica D., Magri F., Imbriani M., Rotondi M., Chiovato L. Exposure to perfluorinated compounds: in vitro study on thyroid cells. Environ. Sci. Pollut. Res. Int. 2014, 22:2287-2294.
18. Corsini E., Avogadro A., Galbiati V., dell'Agli M., Marinovich M., Galli C.L., Germolec D.R. In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs). Toxicol. Appl. Pharmacol. 2011, 250:108-116.
19. Corsini E., Sangiovanni E., Avogadro A., Galbiati V., Viviani B., Marinovich M., Galli C.L., Dell'Agli M., Germolec D.R. In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol. Appl. Pharmacol. 2012, 258:248-255.
20. Cui L., Zhou Q.F., Liao C.Y., Fu J.J., Jiang G.B. Studies on the toxicological effects of PFOA and PFOS on rats using histological observation and chemical analysis. Arch. Environ. Contam. Toxicol. 2009, 56:338-349.
21. Cui L., Liao C.Y., Zhou Q.F., Xia T.M., Yun Z.J., Jiang G.B. Excretion of PFOA and PFOS in male rats during a subchronic exposure. Arch. Environ. Contam. Toxicol. 2010, 58:205-213.
22. Domingo J.L. Health risks of dietary exposure to perfluorinated compounds. Environ. Int. 2012, 40:187-195.
23. EFSA Opinion of the scientific panel on contaminants in the food chain on perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA) and their salts. EFSA J. 2008, 653:1-131.
24. Elcombe C.R., Elcombe B.M., Foster J.R., Chang S.C., Ehresman D.J., Butenhoff J.L. Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR. Toxicology 2012, 293:16-29.
25. Fair P.A., Driscoll E., Mollenhauer M.A., Bradshaw S.G., Yun S.H., Kannan K., Bossart G.D., Keil D.E., Peden-Adams M.M. Effects of environmentally-relevant levels of perfluorooctane sulfonate on clinical parameters and immunological functions in B6C3F1 mice. J. Immunotoxicol. 2011, 8:17-29.
26. Florentin A., Deblonde T., Diguio N., Hautemaniere A., Hartemann P. Impacts of two perfluorinated compounds (PFOS and PFOA) on human hepatoma cells: cytotoxicity but no genotoxicity?. Int. J. Hyg. Environ. Health 2011, 214:493-499.
27. Franke J., Abs V., Zizzadoro C., Abraham G. Comparative study of the effects of fetal bovine serum versus horse serum on growth and differentiation of primary equine bronchial fibroblasts. BMC Vet. Res. 2014, 10:119.
28. Fromme H., Tittlemier S.A., Völkel W., Wilhelm M., Twardella D. Perfluorinated compounds-exposure assessment for the general population in Western countries. Int. J. Hyg. Environ. Health 2009, 212:239-270.
29. Gao B., He X., Liu W., Zhang H., Saito N., Tsuda S. Distribution of perfluoroalkyl compounds in rats: indication for using hair as bioindicator of exposure. J. Expo. Sci. Environ. Epidemiol. 2014, 10.1038/jes.2014.54.
30. Giménez-Bastida J.A., Martínez-Florensa M., Espín J.C., Tomás-Barberán F.A., García-Conesa M.T. A citrus extract containing flavanones represses plasminogen activator inhibitor-1 (PAI-1) expression and regulates multiple inflammatory, tissue repair, and fibrosis genes in human colon fibroblasts. J. Agric. Food Chem. 2009, 57:9305-9315.
31. González-Sarrías A., Larrosa M., Tomás-Barberán F.A., Dolara P., Espín J.C. NF-κB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. Br. J. Nutr. 2010, 104:503-512.
32. Gorrochategui E., Pérez-Albaladejo E., Casas J., Lacorte S., Porte C. Perfluorinated chemicals: differential toxicity, inhibition of aromatase activity and alteration of cellular lipids in human placental cells. Toxicol. Appl. Pharmacol. 2014, 277:124-130.
33. Grandjean P., Andersen E.W., Budtz-Jorgensen E., Nielsen F., Molbak K., Weihe P., Heilmann C. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 2012, 307:391-397.
34. Guo F., Zhong Y., Wang Y., Li J., Zhang J., Liu J., Zhao Y., Wu Y. Perfluorinated compounds in human blood around Bohai Sea, China. Chemosphere 2011, 85:156-162.
35. Henry N.D., Fair P.A. Comparison of in vitro cytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid. J. Appl. Toxicol. 2013, 33:265-272.
36. Hong S., Khim J.S., Wang T., Naile J.E., Park J., Kwon B.O., Song S.J., Ryu J., Codling G., Jones P.D., Lu Y., Giesy J.P. Bioaccumulation characteristics of perfluoroalkyl acids (PFAAs) in coastal organisms from the west coast of South Korea. Chemosphere 2014, pii 14(S0045-6535):00759.
37. Hu X.Z., Hu D.C. Effects of perfluorooctanoate and perfluorooctane sulfonate exposure on hepatoma Hep G2 cells. Arch. Toxicol. 2009, 83:851-861.
38. Hu W., Jones P.D., Upham B.L., Trosko J.E., Lau C., Giesy J.P. Inhibition of gap junctional intercellular communication by perfluorinated compounds in rat liver and dolphin kidney epithelial cell lines in vitro and Sprague-Dawley rats in vivo. Toxicol. Sci. 2002, 68:429-436.
39. Hu W., Jones P.D., DeCoen W., King L., Fraker P., Newsted J., Giesy J.P. Alterations in cell membrane properties caused by perfluorinated compounds. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2003, 135:77-88.
40. Hu Q., Strynar M.J., DeWitt J.C. Are developmentally exposed C57BL/6 mice insensitive to suppression of TDAR by PFOA?. J. Immunotoxicol. 2010, 7:344-349.
41. Jobson T.M., Billington C.K., Hall I.P. Regulation of proliferation of human colonic subepithelial myofibroblasts by mediators important in intestinal inflammation. J. Clin. Invest. 1998, 101:2650-2657.
42. Johansson N., Fredriksson A., Eriksson P. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 2008, 29:160-169.
43. Jones P.D., Hu W., De Coen W., Newsted J.L., Giesy J.P. Binding of perfluorinated fatty acids to serum proteins. Environ. Toxicol. Chem. 2003, 22:2639-2649.
44. Kannan K., Corsolini S., Falandysz J., Fillmann G., Kumar K.S., Loganathan B.G., Mohd M.A., Olivero J., Van Wouwe N., Yang J.H., Aldoust K.M. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ. Sci. Technol. 2004, 38:4489-4495.
45. Keil D.E., Mehlmann T., Butterworth L., Peden-Adams M.M. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicol. Sci. 2008, 103:77-85.
46. Kleszczyński K., Składanowski A.C. Mechanism of cytotoxic action of perfluorinated acids. I. Alteration in plasma membrane potential and intracellular pH level. Toxicol. Appl. Pharmacol. 2009, 234:300-305.
47. 2+ homeostasis. Toxicol. Appl. Pharmacol. 2011, 251:163-168.
48. Kleszczyński K., Gardzielewski P., Mulkiewicz E., Stepnowski P., Skadanowski A.C. Analysis of structure-cytotoxicity in vitro relationship (SAR) for per fluori-nated carboxylic acids. Toxicol. In Vitro 2007, 21:1206-1211.
49. Kleszczyński K., Stepnowski P., Składanowski A.C. Mechanism of cytotoxic action of perfluorinated acids II. Disruption of mitochondrial bioenergetics. Toxicol. Appl. Pharmacol. 2009, 235:182-190.
50. Krug S.M., Schulzke J.D., Fromm M. Tight junction, selective permeability, and related diseases. Semin. Cell. Dev. Biol. 2014, 36:166-176.
51. Lankova D., Lacina O., Pulkrabova J., Hajslova J. The determination of perfluoroalkyl substances, brominated flame retardants and their metabolites in human breast milk and infant formula. Talanta 2013, 117:318-325.
52. Lin A.Y., Panchangam S.C., Tsai Y.T., Yu T.H. Occurrence of perfluorinated compounds in the aquatic environment as found in science park effluent, river water, rainwater, sediments, and biotissues. Environ. Monit. Assess. 2014, 186:3265-3275.
53. Lindstrom A.B., Strynar M.J., Libelo E.L. Polyfluorinated compounds: past, present, and future. Environ. Sci. Technol. 2011, 45:7954-7961.
54. Liu C., Yu K., Shi X., Wang J., Lam P.K., Wu R.S., Zhou B. Induction of oxidative stress and apoptosis by PFOS and PFOA in primary cultured hepatocytes of freshwater tilapia (Oreochromis niloticus). Aquat. Toxicol. 2007, 82:135-143.
55. Luebker D.J., York R.G., Hansen K.J., Moore J.A., Butenhoff J.L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharmacokinetic parameters. Toxicology 2005, 215:149-169.
56. Malinverno G., Colombo I., Visca M. Toxicological profile of hydrofluoropolyethers. Regul. Toxicol. Pharmacol. 2005, 41:228-239.
57. Mao L., Franke J. Hormesis in aging and neurodegeneration-a prodigy awaiting dissection. Int. J. Mol. Sci. 2013, 14:13109-13128.
58. Maras M., Vanparys C.B., Muylle F., Robbens J., Berger J.L., Barber J.L., Blust R., DeCoen W. Estrogen-like properties of fluorotelomer alcohols as revealed by MCF-7 breast cancer cell proliferation. Environ. Health Perspect. 2006, 114:100-105.
59. Mariussen E. Neurotoxic effects of perfluoroalkylated compounds: mechanisms of action and environmental relevance. Arch. Toxicol. 2012, 86:1349-1367.
60. Melzer D., Rice N., Depledge M.H., Henley W.E., Galloway T.S. Association between serum perfluorooctanoic acid (PFOA) and thyroid disease in the U.S. National Health and Nutrition Examination Survey. Environ. Health Perspect. 2010, 118:686-692.
61. Mulkiewicz E., Jastorff B., Składanowski A.C., Kleszczyński K., Stepnowski P. Evaluation of the acute toxicity of perfluorinated carboxylic acids using eukaryotic cell lines, bacteria and enzymatic assays. Environ. Toxicol. Pharmacol. 2007, 23:279-285.
62. Narimatsu S., Nakanishi R., Hanioka N., Saito K., Kataoka H. Characterization of inhibitory effects of perfluorooctane sulfonate on human hepatic cytochrome P450 isoenzymes: focusing on CYP2A6. Chem. Biol. Interact. 2011, 194:120-126.
63. Olsen G.W., Mair D.C., Reagen W.K., Ellefson M.E., Ehresman D.J., Butenhoff J.L., Zobel L.R. Preliminary evidence of a decline in perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations in American Red Cross blood donors. Chemosphere 2007, 68:105-111.
64. Organisation for Economic Co-operation and Development Results of Survey on Production and Use of PFOS and PFOA, Related Substances and Products/Mixtures Containing These Substances 2005, Organisation for Economic Co-operation and Development, Paris.
65. Peden-Adams M.M., Keller J.M., Eudaly J.G., Berger J., Gilkeson G.S., Keil D.E. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol. Sci. 2008, 104:144-154.
66. Peng H., Wei Q., Wan Y., Giesy J.P., Li L., Hu J. Tissue distribution and maternal transfer of poly- and perfluorinated compounds in Chinese Sturgeon (Acipenser sinensis): implications for reproductive risk. Environ. Sci. Technol. 2010, 44:1868-1874.
67. Powell D.W., Pinchuk I.V., Saada J.I., Chen X., Mifflin R.C. Mesenchymal cells of the intestinal lamina propria. Annu. Rev. Physiol. 2011, 73:213-237.
68. Qazi M.R., Bogdanska J., Butenhoff J.L., Nelson B.D., DePierre J.W., Abedi-Valugerdi M. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 2009, 262:207-214.
69. Shan G., Ye M., Zhu B., Zhu L. Enhanced cytotoxicity of pentachlorophenol by perfluorooctane sulfonate or perfluorooctanoic acid in HepG2 cells. Chemosphere 2013, 93:2101-2107.
70. Sinclair E., Mayack D.T., Roblee K., Yamashita N., Kannan K. Occurrence of perfluoroalkyl surfactants in water, fish, and birds from New York State. Arch. Environ. Contam. Toxicol. 2006, 50:398-410.
71. Steenland K., Zhao L., Winquist A., Parks C. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ. Health Perspect. 2013, 121:900-905.
72. Surma M., Zieliński H. What do we know about the risk arising from perfluorinated. Pol. J. Environ. Stud. 2015, 24:11-19.
73. Tilton S.C., Orner G.A., Benninghoff A.D., Carpenter H.M., Hendricks J.D., Pereira C.B., Williams D.E. Genomic profiling reveals an alternate mechanism of hepatic tumor promotion by perfluorooctanoic acid in rainbow trout. Environ. Health Perspect. 2008, 116:1047-1055.
74. Trapecar M., Cencic A. Application of gut cell models for toxicological and bioactivity studies of functional and novel foods. Foods 2012, 1:40-51.
75. Wang T., Wang Y., Liao C., Cai Y., Jiang G. Perspectives on the inclusion of perfuorooctane sulfonate into the Stockholm Convention on persistent organic pollutants. Environ. Sci. Technol. 2009, 43:5171-5175.
76. Yao X., Zhong L. Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. Mutat. Res. 2005, 587:38-44.
77. Zhang X., Chen L., Fei X.C., Ma Y.S., Gao H.W. Binding of PFOS to serum albumin and DNA: insight into the molecular toxicity of perfluorochemicals. BMC Mol. Biol. 2009, 10:16.
78. Zhao H., Chen C., Zhang X., Chen J., Quan X. Phytotoxicity of PFOS and PFOA to Brassica chinensis in different Chinese soils. Ecotoxicol. Environ. Saf. 2011, 74:1343-1347.